YOLFTbeta
2cureX AB

2cureX AB

2CUREX · ST · Healthcare / Biotechnology

0.42SEK-0.06 (-12.13%)

Price History

Full chart

Market Stats

Previous Close0.478
Open0.50
Day Range0.41 – 0.529
52-Week Range0.40 – 3.27
Volume380.70K
Market Cap10.54M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.42
Dividend Yield0.00%
Beta2.93
50-Day Avg1.56
200-Day Avg1.47

About

2cureX AB (publ) operates as a medical technology company in Europe. ts proprietary IndiTreat test family creates various three-dimensional tumoroids derived from fresh samples of colorectal cancer (CRC) tissue that has been obtained from an individual patient's metastatic colorectal cancer. 2cureX AB (publ) was incorporated in 2006 and is based in Landskrona, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEONathaniel Hutley
  • Employees14
  • HeadquartersLilla Strandgatan 19, 261 29, Landskrona, Sweden, 261 29, Sweden
  • Websitehttps://www.2curex.se

Leadership

  • Mr. Ole Thastrup VDCo-Founder & Chairman · b. 1953
  • Nathaniel HutleyInterim CEO & Director
  • Ms. Grith HagelCo-Founder, VP of Innovation & Director · b. 1959
  • Mr. Kenneth Graabek JohansenChief Financial Officer · b. 1976
  • Mr. Jacob ThastrupChief Technology Officer · b. 1979
  • Mr. Manuel FernandezDirector Quality & Regulatory Affairs

Financials

Income Statement

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.23M1.35M47.00K7.67M11.98M15.39M7.39M90.00K155.00K0-
Growth (%)--39.72%-96.51%+16229.79%+56.12%+28.45%-51.98%-98.78%+72.22%-100.00%-
Cost of Revenue208.17K235.99K7.88M431.00K436.00K386.00K353.00K35.50M37.64M4.03M-
Gross Profit2.03M1.11M-7.83M7.24M11.55M15.01M7.04M-9.02M-9.27M-4.03M-
Gross Margin90.68%82.48%-16657.45%94.38%96.36%97.49%95.22%-10016.67%-5981.29%--
Operating Expense2.94M2.67M-3.86M15.68M20.30M37.81M37.23M23.12M27.09M719.00K-
Operating Income-915.03K-1.56M-3.97M-8.44M-8.75M-22.81M-30.19M-32.13M-36.36M-4.74M-2.79M
Operating Margin-40.95%-115.50%-8453.19%-109.92%-73.02%-148.20%-408.50%-35703.33%-23460.00%--
EBITDA-731.51K-1.32M-3.65M-8.01M-8.31M-8.21M-22.13M-29.46M-35.14M-4.13M-2.79M
EBITDA Margin-32.73%-97.76%-7772.34%-104.30%-69.38%-53.31%-299.36%-32732.22%-22668.39%--
Net Income-479.11K-649.01K-3.14M-7.26M-7.93M-7.32M-18.94M-29.77M-32.52M-4.13M-2.61M
Net Income Margin-21.44%-48.18%-6672.34%-94.64%-66.21%-47.56%-256.22%-33077.78%-20979.35%--
R&D--4.63M--------
R&D as % of Total Revenue--9851.06%--------
Interest Expense0052.00K106.00K662.00K240.00K104.00K2.36M1.62M2.00K-
Interest Expense % of Total Revenue0.00%0.00%110.64%1.38%5.52%1.56%1.41%2625.56%1043.23%--

Balance Sheet

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets12.07M10.84M22.85M24.03M37.84M63.04M79.16M47.66M16.28M7.75M-
Total Liabilities3.88M2.93M2.61M10.40M9.77M4.18M4.82M4.62M4.20M2.65M-
Total Equity8.19M7.91M20.24M13.62M28.08M58.86M74.34M43.03M12.08M5.10M-
Cash6.20M7.36M19.98M20.06M33.72M58.58M72.94M44.89M13.40M5.14M-
Net Debt-6.20M-7.36M-19.98M-20.06M-33.72M-58.58M-72.94M-44.89M-13.40M-5.14M-

Cash Flow

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow-2.05M1.21M-4.35M1.15M-7.86M-11.69M-18.43M-27.98M-31.22M-4.63M
Investing Cash Flow-343.16K-338.78K-7.00K-1.20M-20.00K-403.00K-32.00K-541.00K-17.00K5.62M
Financing Cash Flow-117.2716.62M21.84M21.84M37.61M32.55M002.69M
Capital Expenditure112.87K338.78K7.00K1.20M59.00K403.00K32.00K541.00K17.00K0
Free Cash Flow-2.16M867.76K-4.36M-48.00K-7.92M-12.10M-18.46M-28.52M-31.24M-4.63M
FCF to OCF105.50%71.92%100.16%-4.17%100.75%103.45%100.17%101.93%100.05%100.00%

Earnings

Report DateDec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Aug 27, 2020Sep 30, 2020Feb 25, 2021May 27, 2021Aug 26, 2021Nov 25, 2021Feb 24, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022May 25, 2023Aug 24, 2023Nov 23, 2023Feb 22, 2024
EPS Estimate-------------------------
EPS Actual-0.17-0.27-0.28-0.06-0.13-0.14-0.26-0.11-0.17-0.09-0.25-0.06-0.15-0.12-0.35-0.31-0.36-0.45-0.36-0.47-0.40-0.43-0.46-0.58-0.28
Surprise-------------------------
Timing------------After-hoursAfter-hoursPre-marketAfter-hoursPre-market----Pre-marketPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap10.54M
Enterprise Value5.45M
Trailing P/E0.00
Forward P/E0.00
Price / Sales5.34
Price / Book16.84
EPS-0.42
Book Value0.158
Revenue (TTM)1.98M
Gross Profit (TTM)-7.63M
EBITDA-28.62M
Profit Margin0.00%
Operating Margin-1924.40%
Return on Equity-174.78%
Return on Assets-97.99%
Shares Outstanding25.10M
Shares Float13.49M
Beta2.93
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.08Jun 27, 2025

Stock Splits

  • May 2, 2019835:789